Fabrice Andre

Prof. Fabrice Andre is research director at Gustave Roussy and co-developer of the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT). The ESCAT framework provides a standardized classification of genomic alterations from Tier I (ready for clinical use) to Tier X (unknown actionability), widely adopted by molecular tumor boards worldwide. His research also investigates molecular stratification of breast and lung cancer for targeted therapy selection.